The new SARS-CoV-2, responsible for the COVID-19 pandemic, has been threatening public
health worldwide for more than a year. The aim of this work was to evaluate compounds of …

… Our screening have successfully … 2019-nCoV in vitro with EC50 values of 0.008μM. This
work demonstrated the feasibility of accurate virtual drug screening for inhibitors of SARS-CoV-2 …

… dynamics (MD) simulations in search of effective SARS CoV-2 inhibitors [29]. Motivated by
… of potent inhibitors of SARS CoV-2, herein we have performed the virtual screening of total …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused about … coronavirus
disease 2019 (COVID-19). In the current study, we used an in silico approach to screen …

… SARS-CoV-2 is seventh and latest in coronavirus … to SARS-CoV-2. They play a vital role in
RNA transcription, viral replication and new virion formation. This study used virtual screening, …

… virtual screening strategy to discover anti-SARS-CoV-2 compounds from REAL Database –
Enamine. The potent inhibitors of SARS-CoV… The high throughput virtual screening based on …

… Our investigation aimed to screen potential inhibitors against coronavirus … SARS-CoV,
SARS-CoV-2, and MERS-CoV to determine the identity matrix using discovery studio. SARS-CoV-…

… to an era of endemicity with SARS-CoV-2 research, in this work … virtual screening campaign
of the University of Tennessee identified nitrofurantoin and isoniazid as potential SARS-CoV-…

… Molecular dynamics were performed on 5 of the six most promising hits from our virtual
screening in complex with the SARS-CoV-2 M pro ; namely: boceprevir, epirubicin, nelfinavir, …

The recent pandemic caused by SARS-CoV-2 has led the world to a standstill, causing a
medical and economic crisis worldwide. This crisis has triggered an urgent need to discover a …